Breaking News Instant updates and real-time market news.

RGNX

Regenxbio

$53.68

0.62 (1.17%)

, ARPO

Aerpio Pharmaceuticals

$1.00

0.0069 (0.69%)

07:09
04/17/19
04/17
07:09
04/17/19
07:09

Regenxbio names Dr. Steve Pakola as Chief Medical Officer

Regenxbio (RGNX) announced the appointment of Steve Pakola, M.D., as its Senior Vice President and Chief Medical Officer. Dr. Pakola will report to Kenneth Mills Regenxbio's President and CEO. Dr. Pakola joins Regenxbio from Aerpio Pharmaceuticals (ARPO) where he was Chief Medical Officer.

RGNX

Regenxbio

$53.68

0.62 (1.17%)

ARPO

Aerpio Pharmaceuticals

$1.00

0.0069 (0.69%)

RGNX Regenxbio
$53.68

0.62 (1.17%)

02/05/19
02/05/19
UPGRADE
Target $94

Strong Buy
Raymond James upgrades Regenxbio to Strong Buy after pullback
As previously reported, Raymond James analyst Reni Benjamin upgraded Regenxbio to Strong Buy from Outperform, stating that his recent talks with management gave him added information on RGX-314 in patients with wet age-related macular degeneration and an update on the company's other gene therapy programs. He believes the recent pullback in shares presents an attractive opportunity "for risk-tolerant investors" given that the company has four wholly owned assets "poised to deliver data in 2019," Benjamin said. He has a $94 price target on Regenxbio shares.
02/05/19
02/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Covanta (CVA) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Lee saying he expects near-term U.K. project pipeline catalysts to highlight the company's medium-to-long term growth potential. 2. Booking Holdings (BKNG) upgraded to Buy from Hold at Deutsche Bank with analyst Lloyd Walmsley saying Booking's room night growth can accelerate in 2019 as the company "leans back into marketing channels," and this can drive multiple expansion. 3. Regenxbio (RGNX) upgraded to Strong Buy from Outperform at Raymond James with analyst Reni Benjamin saying his recent talks with management gave him added information on RGX-314 in patients with wet age-related macular degeneration and an update on the company's other gene therapy programs. 4. Legg Mason (LM) upgraded to Buy from Neutral at Citi. 5. Nine Energy Services (NINE) upgraded to Buy from Hold at Tudor Pickering. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/25/19
EVER
02/25/19
UPGRADE
EVER
Outperform
Regenxbio upgraded to Outperform from In Line at Evercore ISI
02/25/19
02/25/19
UPGRADE
Target $79

Outperform
Regenxbio upgraded to Outperform ahead of catalysts at Evercore ISI
As previously reported, Evercore ISI analyst Josh Schimmer upgraded Regenxbio (RGNX) to Outperform from In Line, with a $79 price target, ahead of some important catalysts this year. While not without risk and important unanswered question, the analyst sees optionality that skews more to the upside. Further, Schimmer believes the Wall Street Journal article suggesting Roche (RHHBY) may bid for Spark Therapeutics (ONCE) will likely lift all gene therapy company shares, including Regenxbio.
ARPO Aerpio Pharmaceuticals
$1.00

0.0069 (0.69%)

03/18/19
NATL
03/18/19
DOWNGRADE
NATL
Neutral
Aerpio Pharmaceuticals downgraded to Neutral from Buy at National Securities
03/18/19
GUGG
03/18/19
DOWNGRADE
GUGG
Neutral
Aerpio Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
03/19/19
HCWC
03/19/19
DOWNGRADE
HCWC
Neutral
Aerpio Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju downgraded Aerpio Pharmaceuticals to Neutral from Buy without a price target after the company's Time-2b trial failed to meet its primary endpoint in diabetic retinopathy. The analyst steps to the sidelines pending management's clarification on the direction of the program.
03/19/19
CANT
03/19/19
NO CHANGE
Target $3
CANT
Overweight
Aerpio selloff overly discounts ongoing glaucoma program, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle lowered her price target for Aerpio Pharmaceuticals to $3 from $8 after the company announced the Time-2B Phase 2b study missed its primary endpoint in diabetic retinopathy. The shares are currently trading close to cash, which overly discounts the potential for partner milestones and the ongoing glaucoma program, Merle tells investors in a research note. She sees a favorable risk/reward into potential updates on Aerpio's other programs and keeps an Overweight rating on the name.

TODAY'S FREE FLY STORIES

NTDOY

Nintendo

$0.00

(0.00%)

18:05
04/24/19
04/24
18:05
04/24/19
18:05
Hot Stocks
Nintendo says 'Super Mario Maker 2' coming to Switch June 28 »

Nintendo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

ARGO

Argo Group

$74.46

0.515 (0.70%)

18:04
04/24/19
04/24
18:04
04/24/19
18:04
Hot Stocks
Argo Group says Voce making 'false and misleading' statements about company »

Argo Group International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

SJW

SJW Corp.

$61.56

0.3 (0.49%)

18:03
04/24/19
04/24
18:03
04/24/19
18:03
Earnings
SJW Corp. reports Q1 EPS 21c with items, consensus 14c »

Reports Q1 revenue 77.7M$…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

CE

Celanese

$110.96

-1.19 (-1.06%)

18:02
04/24/19
04/24
18:02
04/24/19
18:02
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

ISTR

Investar Holding

$22.45

-0.09 (-0.40%)

18:02
04/24/19
04/24
18:02
04/24/19
18:02
Earnings
Investar Holding reports Q1 EPS 46c, consensus 45c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

18:00
04/24/19
04/24
18:00
04/24/19
18:00
Earnings
Microsoft sees total Q4 revenue at implied $32.2B-$32.9B, consensus $32.63B »

By segment, sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

ISBC

Investors Bancorp

$12.27

0.07 (0.57%)

17:52
04/24/19
04/24
17:52
04/24/19
17:52
Earnings
Investors Bancorp reports Q1 EPS 18c, consensus 20c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 13

    May

  • 21

    May

FB

Facebook

$182.64

-1.13 (-0.61%)

17:51
04/24/19
04/24
17:51
04/24/19
17:51
Hot Stocks
Facebook CEO says 'quite focused on' commerce and payments »

Says "quite focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB

Facebook

$182.64

-1.13 (-0.61%)

17:42
04/24/19
04/24
17:42
04/24/19
17:42
Hot Stocks
Facebook says encrypted communications to be big focus in next couple of years »

Says shift to encrypted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

CLB

Core Laboratories

$72.91

-1.605 (-2.15%)

17:42
04/24/19
04/24
17:42
04/24/19
17:42
Earnings
Core Laboratories sees Q2 EPS 47c-50c, consensus 49c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

CLB

Core Laboratories

$72.91

-1.605 (-2.15%)

17:41
04/24/19
04/24
17:41
04/24/19
17:41
Earnings
Core Laboratories reports Q1 adjusted EPS 44c, consensus 43c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

17:41
04/24/19
04/24
17:41
04/24/19
17:41
Hot Stocks
Microsoft CEO says LinkedIn saw 'record level of engagement' in Q3 »

Says LinkedIn marketing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:40
04/24/19
04/24
17:40
04/24/19
17:40
Hot Stocks
Tesla CEO Musk says large number of vehicle deliveries shifted into Q2 »

Says: Expects 1M robo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

FB

Facebook

$182.64

-1.13 (-0.61%)

17:33
04/24/19
04/24
17:33
04/24/19
17:33
Hot Stocks
Facebook sees changes making mobile ad targeting more difficult »

Says year-over-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:32
04/24/19
04/24
17:32
04/24/19
17:32
Earnings
Breaking Earnings news story on Packaging Corp. »

Packaging Corp sees Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Packaging Corp. »

Packaging Corp reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Earnings
Tesla expects to significantly reduce loss in Q2, return to profitability in Q3 »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

FOLD

Amicus

$13.15

-0.12 (-0.90%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Syndicate
Breaking Syndicate news story on Amicus »

Amicus files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$182.64

-1.13 (-0.61%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Hot Stocks
Facebook says number of ad impressions served across all services rose 32% in Q1 »

Comments taken from Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Earnings
Packaging Corp. reports Q1 adjusted EPS $1.98, consensus $1.96 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Earnings
Tesla sees 2019 capital expenditures of $2.0B-$2.5B »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MEOH

Methanex

$57.37

-1.63 (-2.76%)

17:28
04/24/19
04/24
17:28
04/24/19
17:28
Earnings
Methanex reports Q1 adjusted EPS 73c, consensus 88c »

Reports Q1 revenue $733M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:27
04/24/19
04/24
17:27
04/24/19
17:27
Earnings
Tesla sees energy generation, storage revenue increasing 'significantly' in 2019 »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MKGI

Monaker Group

$2.62

(0.00%)

17:27
04/24/19
04/24
17:27
04/24/19
17:27
Syndicate
Monaker Group files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:26
04/24/19
04/24
17:26
04/24/19
17:26
Earnings
Tesla CEO sees order rate continuing to increase throughout year »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.